Changing trends in the treatment of dry-eye disease

Dogru M., Nakamura M., Shimazaki J., Tsubota K.

2013
Expert Opinion on Investigational Drugs

View publication

Therapeutic Area

Front of the eye (FOTE)
Categories

Disease understanding (epidemiology, diagnosis, QoL, Biomarkers…)

Affiliations

Tokyo Dental College Ichikawa Hospital, Department of Ophthalmology, Chiba, Japan; Ophthalmic Research and Development Center, Santen Pharmaceutical Co. Ltd, 8916-16 Takayama-cho, Ikoma-shi, Nara, Japan; Keio University School of Medicine, Department of Ophthalmology, Tokyo, Japan

Related Publications

Six-month efficacy and safety of oxymetazoline hydrochloride 0.1% in Japanese patients with acquired blepharoptosis: a phase 3 study

Ishikawa H., Oka K., Inoue H.

Tear Biomarkers of Topical Sirolimus in Meibomian Gland Dysfunction: A Randomized Trial

Zhou L.; Shimizu H.; Togashi Y.; Kirihara T.; Yang Y.; Lam C.T.; Shimada H.; Tong L.

Layer-by-layer tear film measurement in patients with dry eye and meibomian gland dysfunction

Arita R., Takeuchi G., Sasai K., Nakamura M., Akiba M.

View all Front of the eye (FOTE) publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022